Ark Solutions Inc (KOSDAQ:203690)
South Korea
· Delayed Price · Currency is KRW 4,425.00
-75.00 (-1.67%)
At close: Jan 22, 2025
Ark Solutions Revenue
In the year 2025, Ark Solutions had annual revenue of 16.08B KRW, down -51.61%. Ark Solutions had revenue of 3.03B in the quarter ending December 31, 2025, a decrease of -64.11%.
Revenue
16.08B
Revenue Growth
-51.61%
P/S Ratio
4.29
Revenue / Employee
292.34M
Employees
55
Market Cap
68.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.08B | -17.15B | -51.61% |
| Dec 31, 2024 | 33.23B | -4.03B | -10.81% |
| Dec 31, 2023 | 37.25B | 10.68B | 40.18% |
| Dec 31, 2022 | 26.58B | -6.26B | -19.07% |
| Dec 31, 2021 | 32.84B | 15.14B | 85.60% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aptamer Sciences | 1.08B |
| Psomagen | 59.19B |
| HLB Pep | 4.96B |
| EyeGene | 3.57B |
| IMGT Co.,Ltd. | 102.33M |
| Progen | 450.00M |
| PanGen Biotech | 13.42B |
| Naturalendo Tech | 22.23B |